Barriers and solutions to Alzheimer's disease clinical trial participation for Black Americans

INTRODUCTION: Black Americans are disproportionately burdened by Alzheimer's disease (AD) relative to other racial groups in the United States and continue to be underrepresented in AD clinical trials. This review explores the primary barriers for participation in clinical trials among Black Am...

Descripción completa

Detalles Bibliográficos
Autores principales: Savold, Jordan, Cole, Michele, Thorpe, Roland J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318422/
https://www.ncbi.nlm.nih.gov/pubmed/37408664
http://dx.doi.org/10.1002/trc2.12402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318422/
https://www.ncbi.nlm.nih.gov/pubmed/37408664
http://dx.doi.org/10.1002/trc2.12402

Ejemplares similares